4.4 Letter

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox

Journal

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 42, Issue 1, Pages 118-119

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/ice.2020.195

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available